This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: Liquiritigenin Inhibits Colorectal Cancer Proliferation, Invasion, and Epithelial-to-Mesenchymal Transition by Decreasing Expression of Runt-Related Transcription Factor 2
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmacological Effects of Natural Compounds · Ginseng Biological Effects and Applications · Phytochemistry and Bioactive Compounds
The published article titled “Liquiritigenin Inhibits Colorectal Cancer Proliferation, Invasion, and Epithelial-to-Mesenchymal Transition by Decreasing Expression of Runt-Related Transcription Factor 2” has been retracted from Oncology Research, Vol. 27, No. 2, 2019, pp. 139–146.
DOI: 10.3727/096504018X15185747911701
URL: https://www.techscience.com/or/v27n2/48638
Following the publication, concerns have been raised about a number of figures in this article. The western blots in this article were presented with atypical, unusually shaped and possibly anomalous protein bands in many cases.
The authors were contacted and invited to comment on the concerns raised and to provide the original, unmodified figures, but did not respond. The Editors-in-Chief therefore no longer have confidence in the integrity of the data in this article and decided to retract this article.
All authors have not responded to correspondence about this retraction. As a responsible publisher, we hold the reliability and integrity of our published content in high regard. We deeply regret any inconvenience caused by this situation to our readers and all concerned parties.